We are live on ! Find out more
ZNTL icon

Zentalis Pharmaceuticals
ZNTL

95 hedge funds and large institutions have $1.58B invested in Zentalis Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 26

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.33% less ownership

Funds ownership: 91.85% → 88.52% (-3.3%)

11% less funds holding

Funds holding: 107 → 95 (-12)

19% less capital invested

Capital invested by funds: $1.94B → $1.58B (-$361M)

48% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 25

Holders
95
Holders Change
-12
Holders Change %
-11.21%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
38
Reduced
26
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$26.9M
2
State Street
State Street
Massachusetts
+$24.9M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$11.7M
4
PCH
Polar Capital Holdings
United Kingdom
+$9.69M
5
APM
Avidity Partners Management
Texas
+$5.52M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$54.5M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$26.3M
3
Capital World Investors
Capital World Investors
California
-$20.7M
4
Citadel Advisors
Citadel Advisors
Florida
-$19.3M
5
RG
Redmile Group
California
-$8.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$5.59M +$188K +4,357 +3%
Millennium Management
27
Millennium Management
New York
$5.56M +$5.52M +128,229 New
N
28
Nuveen
North Carolina
$5.07M +$470K +10,908 +10%
Bank of America
29
Bank of America
North Carolina
$3.93M +$1.83M +42,478 +88%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.9M -$294K -6,821 -7%
Citigroup
31
Citigroup
New York
$3.57M +$3.03M +70,352 +585%
AAA
32
Affinity Asset Advisors
New York
$3.36M +$3.34M +77,500 New
Rafferty Asset Management
33
Rafferty Asset Management
New York
$2.84M +$2.56M +59,373 +965%
Verition Fund Management
34
Verition Fund Management
Connecticut
$2.81M +$2.29M +53,148 +459%
GI
35
GAMCO Investors
Connecticut
$2.72M +$2.7M +62,711 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$2.53M -$232K -5,396 -8%
PVI
37
Pura Vida Investments
New York
$2.46M +$2.44M +56,776 New
Morgan Stanley
38
Morgan Stanley
New York
$2.3M -$2.06M -47,851 -47%
Goldman Sachs
39
Goldman Sachs
New York
$2.25M -$7.41M -172,174 -77%
PCM
40
Pentwater Capital Management
Florida
$1.95M – – –
MCM
41
Moore Capital Management
New York
$1.95M +$1.94M +44,993 New
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$1.88M -$5.64K -131 -0.3%
Swiss National Bank
43
Swiss National Bank
Switzerland
$1.81M +$47.4K +1,100 +3%
GAMA
44
Graticule Asia Macro Advisors
New York
$1.8M +$1.79M +41,550 New
IHAM
45
Integral Health Asset Management
New York
$1.74M +$1.72M +40,000 New
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$1.68M -$56K -1,300 -3%
Two Sigma Advisers
47
Two Sigma Advisers
New York
$1.6M +$1.03M +23,900 +182%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$1.33M -$79.6K -1,848 -6%
TD Asset Management
49
TD Asset Management
Ontario, Canada
$1.27M +$203K +4,722 +19%
Norges Bank
50
Norges Bank
Norway
$1.25M +$822K +19,082 +194%
1
2
3 4 5

ZNTL Hedge Fund Activity: Q1 2021 in Review

95 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Zentalis Pharmaceuticals (ZNTL) for Q1 2021, worth a combined $1.58B — down 19% from $1.94B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ZNTL and 13 opened new positions — a net loss of 12 holders — while 26 trimmed existing stakes and 38 added.

The largest buyer was Federated Hermes, adding an estimated $26.9M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $54.5M sold.

  • 95 institutional investors held Zentalis Pharmaceuticals (ZNTL) as of Q1 2021, down from 107 in Q4 2020.
  • Funds reported $1.58B of Zentalis Pharmaceuticals stock for Q1 2021, down 19% quarter-over-quarter.
  • 13 funds opened new Zentalis Pharmaceuticals positions in Q1 2021 and 25 closed out, a net change of -12 holders.
  • The largest Zentalis Pharmaceuticals buyer in Q1 2021 was Federated Hermes, an estimated $26.9M added.
  • The largest Zentalis Pharmaceuticals seller in Q1 2021 was Perceptive Advisors, an estimated $54.5M sold.

Based on aggregated 13F filings for Q1 2021.